← Open Payments lookup

DOROTHY WOMACK: Open Payments

NPI 1003590282 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,284 in 164 payments from 16 companies in 2025. Trend: 2023 $590 · 2024 $1,645 · 2025 $3,284

Food & beverage: $2,830Education: $454
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.12$459
ABBVIE INC.32$423
GENZYME CORPORATION16$413
Janssen Biotech, Inc.15$335
E.R. Squibb & Sons, L.L.C.19$317
UCB, Inc.14$290
Galderma Laboratories, L.P.17$238
Novartis Pharmaceuticals Corporation12$229
SUN PHARMACEUTICAL INDUSTRIES INC.4$167
Lilly USA, LLC8$134

Products named: DUPIXENT, TREMFYA, Sotyktu, Bimzelx, NEMLUVIO, RINVOQ, SKYRIZI, COSENTYX.

Industry payments across TX — which companies pay providers there.